$OTRK
Ontrak, Inc.

2017 Q2 Form 10-Q Financial Statement

#000143774917014822 Filed on August 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $1.665M $1.223M
YoY Change 36.14% 159.11%
Cost Of Revenue $1.332M $1.162M
YoY Change 14.63% 119.66%
Gross Profit $333.0K $61.00K
YoY Change 445.9% -207.02%
Gross Profit Margin 20.0% 4.99%
Selling, General & Admin $2.940M $2.140M
YoY Change 37.38% -11.57%
% of Gross Profit 882.88% 3508.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $40.00K $30.00K
YoY Change 33.33% 0.0%
% of Gross Profit 12.01% 49.18%
Operating Expenses $4.317M $3.330M
YoY Change 29.64% 11.71%
Operating Profit -$2.652M -$2.107M
YoY Change 25.87% -16.02%
Interest Expense $539.0K $591.0K
YoY Change -8.8% -46.76%
% of Operating Profit
Other Income/Expense, Net $6.960M -$510.0K
YoY Change -1464.71% -5200.0%
Pretax Income $13.93M -$4.717M
YoY Change -395.23% 706.32%
Income Tax $1.000K $3.000K
% Of Pretax Income 0.01%
Net Earnings $13.93M -$4.720M
YoY Change -395.02% 704.09%
Net Earnings / Revenue 836.34% -385.94%
Basic Earnings Per Share $1.00 -$0.51
Diluted Earnings Per Share $0.97 -$0.51
COMMON SHARES
Basic Shares Outstanding 13.89M 9.168M
Diluted Shares Outstanding 14.30M 9.168M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.200M $100.0K
YoY Change 9100.0% -50.0%
Cash & Equivalents $9.222M $52.00K
Short-Term Investments
Other Short-Term Assets $200.0K $300.0K
YoY Change -33.33% -50.0%
Inventory
Prepaid Expenses
Receivables $1.000M $900.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.39M $1.291M
YoY Change 704.57% 30.8%
LONG-TERM ASSETS
Property, Plant & Equipment $454.0K $407.0K
YoY Change 11.55% 29.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $371.0K $371.0K
YoY Change 0.0% -28.79%
Total Long-Term Assets $825.0K $778.0K
YoY Change 6.04% -16.07%
TOTAL ASSETS
Total Short-Term Assets $10.39M $1.291M
Total Long-Term Assets $825.0K $778.0K
Total Assets $11.21M $2.069M
YoY Change 441.9% 8.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $656.0K $734.0K
YoY Change -10.63% 20.33%
Accrued Expenses $1.700M $2.500M
YoY Change -32.0% 13.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $6.100M
YoY Change -100.0% 161.13%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.735M $17.32M
YoY Change -72.67% 190.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $100.0K
YoY Change -100.0%
Other Long-Term Liabilities $100.0K $2.100M
YoY Change -95.24% 75.0%
Total Long-Term Liabilities $100.0K $2.200M
YoY Change -95.45% 83.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.735M $17.32M
Total Long-Term Liabilities $100.0K $2.200M
Total Liabilities $4.859M $19.46M
YoY Change -75.03% 171.05%
SHAREHOLDERS EQUITY
Retained Earnings -$287.6M -$270.8M
YoY Change 6.19% 6.05%
Common Stock $2.000K $6.000K
YoY Change -66.67% 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.353M -$17.39M
YoY Change
Total Liabilities & Shareholders Equity $11.21M $2.069M
YoY Change 441.9% 8.1%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $13.93M -$4.720M
YoY Change -395.02% 704.09%
Depreciation, Depletion And Amortization $40.00K $30.00K
YoY Change 33.33% 0.0%
Cash From Operating Activities -$1.590M -$1.430M
YoY Change 11.19% -20.11%
INVESTING ACTIVITIES
Capital Expenditures -$80.00K -$20.00K
YoY Change 300.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$80.00K -$20.00K
YoY Change 300.0% 100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.61M 1.240M
YoY Change 755.65% -33.33%
NET CHANGE
Cash From Operating Activities -1.590M -1.430M
Cash From Investing Activities -80.00K -20.00K
Cash From Financing Activities 10.61M 1.240M
Net Change In Cash 8.940M -210.0K
YoY Change -4357.14% -450.0%
FREE CASH FLOW
Cash From Operating Activities -$1.590M -$1.430M
Capital Expenditures -$80.00K -$20.00K
Free Cash Flow -$1.510M -$1.410M
YoY Change 7.09% -20.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 cats Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-430000
CY2016Q2 cats Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
cats Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-1356000
cats Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
CY2017Q2 cats Gain Loss On Issuance Of Common Stock
GainLossOnIssuanceOfCommonStock
-145000
CY2016Q2 cats Gain Loss On Issuance Of Common Stock
GainLossOnIssuanceOfCommonStock
cats Gain Loss On Issuance Of Common Stock
GainLossOnIssuanceOfCommonStock
-145000
cats Gain Loss On Issuance Of Common Stock
GainLossOnIssuanceOfCommonStock
CY2017Q2 cats Warrant Liabilities Noncurrent
WarrantLiabilitiesNoncurrent
38000
CY2016Q4 cats Warrant Liabilities Noncurrent
WarrantLiabilitiesNoncurrent
5307000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
656000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
870000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1704000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1620000
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
293913000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
254390000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
230000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3335000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
660000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
413701
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
811154
CY2017Q2 us-gaap Assets
Assets
11212000
CY2016Q4 us-gaap Assets
Assets
3104000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
10387000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
2323000
CY2017Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
106000
CY2017Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14000
CY2016Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
31000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
851000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
916000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9222000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52000
CY2017Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
106000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8371000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-864000
CY2017Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
9100000
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15889171
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9214743
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15889171
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9214743
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2017Q2 us-gaap Cost Of Services
CostOfServices
1332000
CY2016Q2 us-gaap Cost Of Services
CostOfServices
1162000
us-gaap Cost Of Services
CostOfServices
2697000
us-gaap Cost Of Services
CostOfServices
2128000
CY2017Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0
CY2016Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
216000
CY2017Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
72000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
117000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2368000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1525000
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
45000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
84000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
84000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64000
CY2017Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
10700000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
132000
CY2016Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1500000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-2800000
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
CY2016Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8122000
CY2017Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
9796000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.97
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1171000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2089000
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6950000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1769000
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
522000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
750000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2940000
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2136000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5569000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4323000
CY2017Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1665000
CY2016Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1223000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
3487000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4717000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7841000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9007000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1951000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13926000
us-gaap Income Taxes Paid
IncomeTaxesPaid
40000
us-gaap Income Taxes Paid
IncomeTaxesPaid
37000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
164000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
397000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
169000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
339000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
843000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1118000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-39000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-45000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-242000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-245000
CY2017Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
414000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
CY2017Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
14000
CY2016Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
10000
us-gaap Interest And Other Income
InterestAndOtherIncome
28000
us-gaap Interest And Other Income
InterestAndOtherIncome
75000
CY2017Q2 us-gaap Interest Expense
InterestExpense
539000
CY2016Q2 us-gaap Interest Expense
InterestExpense
591000
us-gaap Interest Expense
InterestExpense
3406000
us-gaap Interest Expense
InterestExpense
924000
us-gaap Interest Paid
InterestPaid
us-gaap Interest Paid
InterestPaid
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
181000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
CY2017Q2 us-gaap Liabilities
Liabilities
4859000
CY2016Q4 us-gaap Liabilities
Liabilities
28432000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11212000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3104000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4735000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22977000
CY2017Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
38000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
11707000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2095000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
178000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
420000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16458000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1300000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-127000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3209000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2949000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
13925000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-4720000
us-gaap Net Income Loss
NetIncomeLoss
-7843000
us-gaap Net Income Loss
NetIncomeLoss
-9012000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
43000
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
4317000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
3330000
us-gaap Operating Expenses
OperatingExpenses
8350000
us-gaap Operating Expenses
OperatingExpenses
6515000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2652000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2107000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4863000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4564000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
540000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
575000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
371000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
371000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1667000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
-16000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
127000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
234000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2185000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
454000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
410000
CY2017Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
987000
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1052000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
4363000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
21000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
90000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-287562000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-279719000
us-gaap Share Based Compensation
ShareBasedCompensation
159000
us-gaap Share Based Compensation
ShareBasedCompensation
349000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
6353000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-25328000
CY2017Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
10728000
CY2016Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1507000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
132000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2844000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14299000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9168000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11578000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9168000
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13885000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9168000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11578000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9168000

Files In Submission

Name View Source Status
0001437749-17-014822-index-headers.html Edgar Link pending
0001437749-17-014822-index.html Edgar Link pending
0001437749-17-014822.txt Edgar Link pending
0001437749-17-014822-xbrl.zip Edgar Link pending
cats-20170630.xml Edgar Link completed
cats-20170630.xsd Edgar Link pending
cats-20170630_cal.xml Edgar Link unprocessable
cats-20170630_def.xml Edgar Link unprocessable
cats-20170630_lab.xml Edgar Link unprocessable
cats-20170630_pre.xml Edgar Link unprocessable
cats20170630_10q.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending